Your browser doesn't support javascript.
loading
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
Dive, C; Smith, R A; Garner, E; Ward, T; George-Smith, S St; Campbell, F; Greenhalf, W; Ghaneh, P; Neoptolemos, J P.
Affiliation
  • Dive C; Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK.
Br J Cancer ; 102(3): 577-82, 2010 Feb 02.
Article in En | MEDLINE | ID: mdl-20051949
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Biomarkers, Tumor / Keratin-18 Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2010 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Biomarkers, Tumor / Keratin-18 Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2010 Document type: Article Affiliation country: